Stericycle Inc (SRCL) Forecast, Price Target & Analyst Ratings
NASDAQ:SRCL • US8589121081
61.98 USD
+0.51 (+0.83%)
At close: Nov 1, 2024
61.98 USD
0 (0%)
After Hours: 11/1/2024, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Stericycle Inc (SRCL).
Forecast Snapshot
Consensus Price Target
$63.01
+ 1.66% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2024
EPS Estimate$0.62
Revenue Estimate695.79M
ChartMill Buy Consensus
71.43%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$63.01
Upside
+ 1.66%
From current price of $61.98 to mean target of $63.01, Based on 14 analyst forecasts
Low
$61.47
Median
$63.24
High
$65.10
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for SRCL. The average price target is 63.01 USD. This implies a price increase of 1.66% is expected in the next year compared to the current price of 61.98.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
71.43%
SRCL was analyzed by 14 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about SRCL.
In the previous month the buy percentage consensus was at a similar level.
SRCL was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-06-04 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-06-04 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-06-04 | Truist Securities | Maintains | Hold -> Hold |
| 2024-04-29 | Truist Securities | Maintains | Hold -> Hold |
| 2024-04-26 | Baird | Maintains | Neutral -> Neutral |
| 2024-03-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-01 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2024-02-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-29 | Stifel | Maintains | Buy -> Buy |
| 2024-02-29 | Truist Securities | Maintains | Hold -> Hold |
| 2023-11-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-01 | Stifel | Reiterate | Buy -> Buy |
| 2023-06-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-06-02 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-01 | RBC Capital | Reiterate | Outperform |
| 2023-04-18 | Truist Securities | Initiate | Hold |
| 2023-02-24 | Baird | Downgrade | Outperform -> Neutral |
| 2022-08-08 | RBC Capital | Maintains | Outperform |
| 2022-05-12 | Berenberg | Downgrade | Buy -> Hold |
| 2022-02-25 | Baird | Maintains | Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2024
EPS Estimate$0.62
Revenue Estimate695.79M
Revenue Q2Q6.72%
EPS Q2Q15.28%
Number of Analysts8
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-1.10%
EPS (1 Month)
0.00%
EPS (3 Months)
-2.75%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 1.1% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.647B -1.07% | 2.705B 2.18% | 2.659B -1.68% | 2.775B 4.35% | 2.864B 3.21% | 3.003B 4.85% | 3.15B 4.90% | 3.289B 4.41% | 3.451B 4.93% | 3.603B 4.40% | 3.761B 4.39% | |
| EBITDA YoY % growth | 458.4M -6.08% | 432.2M -5.72% | 483.4M 11.85% | 472.42M -2.27% | 542.68M 14.87% | 634.44M 16.91% | 733.38M 15.59% | 778.26M 6.12% | 829.26M 6.55% | 873.12M 5.29% | 919.02M 5.26% | |
| EBIT YoY % growth | 234.5M -7.89% | 199.7M -14.84% | 266.9M 33.65% | 313.09M 17.31% | 389.95M 24.55% | 489.6M 25.55% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 8.86% | 7.38% | 10.04% | 11.28% | 13.62% | 16.30% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 2.20 -2.22% | 2.05 -6.82% | 1.89 -7.80% | 2.32 22.51% | 2.85 22.91% | 3.70 30.11% | 4.52 22.04% | 4.98 10.16% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.62 15.28% | 0.56 -1.58% | 0.67 34.64% | 0.70 32.79% | 0.78 24.52% |
| Revenue Q2Q % growth | 695.79M 6.72% | 698.7M 5.08% | 707.88M 7.00% | 717.06M 10.59% | 718.08M 3.20% |
| EBITDA Q2Q % growth | 125.51M -54.06% | 121.38M 4.46% | 134.64M -16.06% | 139.74M 17.91% | 149.94M 19.46% |
| EBIT Q2Q % growth | 87.571M 54.45% | 61.608M -1.74% | 62.424M 16.03% | 65.586M -31.38% | 72.012M -17.77% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.13%
EPS Next 5 Year
21.37%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.39%
Revenue Next 5 Year
3.90%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
32.09%
EBIT Next 5 Year
23.10%
Stericycle Inc / SRCL Forecast FAQ
What do analysts expect the price target to be for Stericycle Inc (SRCL)?
14 analysts have analysed SRCL and the average price target is 63.01 USD. This implies a price increase of 1.66% is expected in the next year compared to the current price of 61.98.
Can you provide the consensus estimates for Stericycle Inc next earnings?
The consensus EPS estimate for the next earnings of Stericycle Inc (SRCL) is 0.62 USD and the consensus revenue estimate is 695.79M USD.
Can you provide the expected long term growth rate for Stericycle Inc stock?
The expected long term growth rate for Stericycle Inc (SRCL) is 3.39%.